Metagenomic analysis of Crohn's disease patients identifies changes in the virome and microbiome related to disease status and therapy, and detects potential interactions and biomarkers

Inflammatory Bowel Diseases

Volumn 21, Issue 11, 2015, Pages 2515-2532

  Pérez Brocal, Vicente ^a,b,c   García López, Rodrigo ^a,b,c   Nos, Pilar ^d,e   Beltrán, Belén ^d,e   Moret, Inés ^e,f   Moya, Andrés ^a,b,c  

^a Vaccine Research   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

Author keywords

16S rRNA gene profiling; biomarkers; Crohn's disease; metagenomics; virome

Indexed keywords

BACTERIAL DNA; RNA 16S; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL GENOME; BACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FECES; FEMALE; GENOME; HUMAN; INTESTINE BIOPSY; MALE; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; MIDDLE AGED; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS; TAXONOMIC RANK; VIROME; VIRUS; VIRUS GENOME; YOUNG ADULT; CASE CONTROL STUDY; GENETICS; METAGENOME; MICROBIOLOGY; MICROFLORA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIROLOGY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CROHN DISEASE; DNA, BACTERIAL; DNA, VIRAL; FECES; FEMALE; HUMANS; MALE; METAGENOME; METAGENOMICS; MICROBIOTA; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 84945278237     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000549     Document Type: Article

References (53)

1. Hubbard VM, Cadwell K. Viruses, autophagy genes, and Crohn's disease. Viruses. 2011;3:1281-1311.
2. Abdullah M, Syam AF, Simadibrata M, et al. New insights on the pathomechanisms of inflammatory bowel disease. J Dig Dis. 2013;14:455-462.
3. Manichanh C, Borruel N, Casellas F, et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9:599-608.
4. Xu XR, Liu CQ, Feng BS, et al. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2014;20:3255-3264.
5. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780-13785.
6. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594.
7. Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease. Physiol Rev. 2010;90:859-904.
8. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010;141:1135-1145.
9. Khan RR, Lawson AD, Minnich LL, et al. Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:328-333.
10. Pironi L, Bonvicini F, Gionchetti P, et al. Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol. 2009;47:1591-1595.
11. Weinberg I, Neuman T, Margalit M, et al. Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma. J Clin Microbiol. 2009, 47:1588-1590.
12. Verdonk RC, Haagsma EB, Kleibeuker JH, et al. Cytomegalovirus infection increases the risk for inflammatory bowel disease. Am J Pathol. 2010; 176:3098.
13. Nyström N, Berg T, Lundin E, et al. Human enterovirus species B in ileocecal Crohn's disease. Clin Transl Gastroenterol. 2013;4:e38.
14. Gorski A, Gorski A, Dabrowska K, et al. New insights into the possible role of bacteriophages in host defense and disease. Med Immunol. 2003;2:2.
15. Lepage P, Colombet J, Marteau P, et al. Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut. 2008;57:424-425.
16. Reyes A, Semenkovich NP, Whiteson K, et al. Going viral: next generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol. 2012;10:607-617.
17. Brüssow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev. 2004;68:560-602.
18. Fortier LC, Sekulovic O. Importance of prophages to evolution and virulence of bacterial pathogens. Virulence. 2013;4:354-365.
19. Muniesa M, Hammerl JA, Hertwig S, et al. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol. 2012;78:4065-4073.
20. Colomer-Lluch M, Jofre J, Muniesa M. Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples. PLoS One. 2011; 6:e17549.
21. De Paepe M, Leclerc M, Tinsley CR, et al. Bacteriophages: an underestimated role in human and animal health? Front Cell Infect Microbiol. 2014;4:39.
22. Breitbart M, Hewson I, Felts B, et al. Metagenomic analyses of an uncultured viral community from human feces. J Bacteriol. 2003;185:6220-6223.
23. Breitbart M, Haynes M, Kelley S, et al. Viral diversity and dynamics in an infant gut. Res Microbiol. 2008;159:367-373.
24. Zhang T, Breitbart M, Lee WH, et al. RNA viral community in human feces: prevalence of plant pathogenic viruses. Plos Biol. 2006;4:e3.
25. Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466:334-338.
26. Kim M-S, Park E-J, Roh SW, et al. Diversity and abundance of singlestranded DNA viruses in human feces. Appl Environ Microbiol. 2011;77: 8062-8070.
27. Minot S, Sinha R, Chen J, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011;21:1616-1625.
28. Minot S, Bryson A, Chehoud C, et al. Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A. 2013;110:12450-12455.
29. Pérez-Brocal V, García-López R, Vázquez-Castellanos JF, et al. Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach. Clin Transl Gastroenterol. 2013;4:e36.
30. Wagner J, Maksimovic J, Farries G, et al. Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm Bowel Dis. 2013;19:1598-1608.
31. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: opensource, platformindependent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537-7541.
32. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-Dhroughput community sequencing data. Nat Methods. 2010;2:335-336.
33. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460-2461.
34. Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261-5267.
35. Caporaso JG, Bittinger K, Bushman FD, et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics. 2010;26:266-267.
36. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011;27:863-864.
37. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357-359.
38. Leplae R, Lima-Mendez G, Toussaint A, et al. ACLAME: A CLAssification of Mobile genetic Elements, update 2010. Nucleic Acids Res. 2010;38:D57-D61.
39. R Development Core Team. R. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
40. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.
41. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15:382-392.
42. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146: 1489-1499.
43. Cao Y, Shen J, Ran ZH. Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-Analysis and systematic review of the literature. Gastroenterol Res Pract. 2014;2014:872725.
44. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
45. Stephen AM, Cummings JH. The microbial contribution to human faecal mass. J Med Microbiol. 1980;13:45-56.
46. Rosario K, Symonds EM, Sinigalliano C, et al. Pepper mild mottle virus as an indicator of fecal Pollution. Appl Environ Microbiol. 2009;75:7261-7264.
47. Colson P, Richet H, Desnues C, et al. Pepper mild mottle virus, a plant virus associated with specific immune responses, fever, abdominal pains, and pruritus in humans. PLoS One. 2010;5:e10041.
48. Liu R, Vaishnav RA, Roberts AM, et al. Humans have antibodies against a plant virus: evidence from tobacco mosaic virus. PLoS One. 2013;8:e60621.
49. Rebolledo-Mendez JD, Vaishnav RA, Cooper NG, et al. Cross-kingdom sequence similarities between human micro-RNAs and plant viruses. Commun Integr Biol. 2013;6:e24951.
50. De Vlaminck I, Khush KK, Strehl C, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell. 2013; 155:1178-1187.
51. Madsen CD, Eugen-Olsen J, Kirk O, et al. TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patients. HIV Clin Trials. 2002;3:287-295.
52. Thom K, Petrik J. Progression towards AIDS leads to increased Torque teno virus and Torque teno minivirus titers in tissues of HIV infected individuals. J Med Virol. 2007;79:1-7.
53. McElvania TeKippe E, Wylie KM, Deych E, et al. Increased prevalence of anellovirus in pediatric patients with fever. PLoS One. 2012;7:e50937.